arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

ADC Therapeutics SA

ADCT

$1.31 ▲ +0.08 (+6.50%) at close

18 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

ADC Therapeutics SA shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $203.1M

Dividend Yield —

Revenue Growth 2.2% ↗

Op. Margin -132.0% ↘

ROIC 11.1% ↘

FCF / Share $-0.08 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

18-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$19.25M

↑ +2.2% —

Net Income Profit after all expenses

$-16.57M

↑ +70.8% —

Operating Margin Operating profit as % of sales

-132.0%

↓ -9.1% 1th

FCF / Share Free cash flow per share

$-0.08

↑ +60.5% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Revenue Growth YoY (%)	2.2% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-73%)	-9.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-218%)	36.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+354%)	-11.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-238%)	8.2% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	27.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+245%)	0.7% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-91%)	27.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+242%)	-9.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-221%)	-4.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-162%)	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	78.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	28.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-31.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	35.7% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	74.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	26.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	36.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	23.3% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	70.8% Excellent ↑ Excellent Improving Year-over-year change in net income	14.6% Fair ↑ Fair Improving Year-over-year change in net income	79.1% Excellent ↑ Excellent Improving Year-over-year change in net income	6.8% Fair ↓ Fair Declining Year-over-year change in net income	-55.0% Weak ↓ Weak Declining Year-over-year change in net income	17.2% Good ↓ Good Declining Year-over-year change in net income	63.9% Excellent ↑ Excellent Improving Year-over-year change in net income	5.9% Fair ↓ Fair Declining Year-over-year change in net income	25.3% Excellent Excellent Year-over-year change in net income	21.5% Good Good Year-over-year change in net income	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	63.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	2.3% Caution Caution Year-over-year change in free cash flow	—	—	—	-166.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-0.1% Weak Weak Compound annual revenue growth over 3 years	3.2% Caution Caution Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Operating Margin (%) (%)	-132.0% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-980%)	-121.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-907%)	-77.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-618%)	-188.5% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1357%)	-234.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1662%)	-123.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-924%)	-191.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1379%)	-192.6% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1384%)	-166.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1212%)	-186.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1341%)	-238.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1687%)	-249.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1763%)	-205.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1471%)	-264.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1862%)	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-86.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-817%)	-158.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1418%)	-27.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-332%)	-249.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2178%)	-300.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2606%)	-167.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1497%)	-181.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1614%)	-238.1% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2084%)	-209.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1849%)	-258.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2251%)	—	-322.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2787%)	-253.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2214%)	-312.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2705%)	—	—	—	—
FCF Margin (%) (%)	-61.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-142.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-135.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-180.4% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	—	-245.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-129.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-247.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-190.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-257.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-187.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-86.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	4.86x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.47x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Return on Invested Capital (%)	11.1% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	11.7% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	10.3% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	17.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	9.4% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	16.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	17.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	13.7% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	21.3% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	44.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	159.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-139.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	7.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-52%)	15.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	17.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	28.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+90%)	16.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+8%)	15.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	25.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+70%)	27.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+85%)	24.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+60%)	57.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+282%)	72.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+385%)	248.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1556%)	-208.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1493%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Interest Coverage (x)	-7.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-2.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.71x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-2.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.69x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.85x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-219.11M	$-231.01M	$-261.34M	$-234.74M	$-264.56M	$-194.70M	$-250.87M	$-274.27M	$-300.12M	$-234.28M	$-278.60M	—	—	—	$-326.44M	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Revenue per Share (USD)	$0.12	$0.14	—	$0.12	$0.17	$0.21	—	$0.18	$0.18	$0.22	—	$0.18	$0.24	$0.24	—	—	—	—
Basic EPS, GAAP (USD)	$-0.11	$-0.21	$0.02	$-0.30	$-0.50	$-0.36	$-0.27	$-0.42	$-0.38	$-0.56	$-1.04	$-0.57	$-0.60	$-0.73	—	—	—	—
Free Cash Flow per Share (USD)	$-0.08	$-0.19	—	$-0.22	—	$-0.53	—	—	—	$-0.54	—	$-0.45	$-0.44	$-0.20	—	—	—	—
Book Value per Share (USD)	$-1.79	$-1.70	$-1.48	$-2.11	$-1.77	$-2.40	$-2.05	$-1.78	$-1.36	$-2.35	$-1.80	$-0.78	$-0.24	$0.35	$0.99	—	—	—
Tangible Book Value per Share (USD)	$-1.79	$-1.70	$-1.48	$-2.11	$-1.77	$-2.40	$-2.05	$-1.78	$-1.36	$-2.35	$-1.80	$-0.78	$-0.24	$0.35	$0.99	—	—	—
Basic Weighted Avg Shares (shares)	155.02M	154.14M	—	136.45M	113.74M	107.20M	—	104.82M	95.69M	82.55M	—	82.26M	81.47M	80.81M	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Working Capital (USD)	$175.38M	$209.14M	$236.17M	$225.10M	$254.16M	$200.19M	$210.78M	$265.33M	$297.73M	$227.22M	$268.62M	—	—	—	$353.04M	—	—	—
Total Equity (USD)	$-228.21M	$-216.38M	$-185.83M	$-238.18M	$-199.18M	$-238.22M	$-202.64M	$-171.95M	$-131.67M	$-194.45M	$-148.25M	$-64.25M	$-19.70M	$28.42M	$79.45M	$154.03M	—	—

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q4 FY2020 Dec 31, 2020 20-F ↗	Q4 FY2019 Dec 31, 2019 20-F ↗
Sales/Revenue/Turnover (USD)	$19.25M	$20.85M	$23.06M	$16.43M	$18.84M	$23.03M	$16.91M	$18.46M	$17.41M	$18.05M	$16.79M	$14.49M	$19.28M	$18.99M	—	—	—	—
Depreciation Expense (USD)	—	—	$0.00	$0.00	$362.00K	$342.00K	$341.00K	$336.00K	$326.00K	$331.00K	$335.00K	$316.00K	$273.00K	$263.00K	—	—	—	—
Net Income, GAAP (USD)	$-16.57M	$-32.97M	$-6.41M	$-40.97M	$-56.65M	$-38.60M	$-30.73M	$-43.97M	$-36.54M	$-46.61M	$-85.03M	$-46.73M	$-48.92M	$-59.37M	—	—	—	—
Operating Cash Flow (USD)	$-11.81M	$-29.71M	$-31.12M	$-29.63M	—	$-56.33M	$-21.85M	—	—	$-44.09M	$-31.63M	$-36.67M	$-34.99M	$-15.39M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 18 quarters

ADC Therapeutics SA

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ADCT with peers